The first and only multivariate biomarker blood test
that provides accurate measurement of MS disease activity.
No data at the biological level
With current tools, changes in multiple sclerosis disease activity are often invisible—until it’s too late.
for faster, smarter intervention
We’re changing that.
Introducing our first-in-class disease activity blood test, which provides real-time assessment of the underlying biology, pathways, mechanisms, and cell types involved in a patient’s MS.
Our multi-protein assay is a dynamic measure of immune modulation, inflammation, myelin biology, and neuroaxonal integrity validated through an extensive multiple sclerosis research and development process and clinical study.
Address real, debilitating issues in MS care
Finally, a solution to quantitatively measure subclinical multiple sclerosis disease activity and detect relapses that can be used to identify suboptimal responses to current interventions. This is only the beginning—we’re at work
on other serum-based tests to bring additional insights to light.
Conduct routine surveillance
Evaluate stability vs. slow decline
Monitor new MS symptoms - evaluation for relapse
Monitor patients who have been discontinued from DMTs
The Octave Bioscience Clinical Laboratory is certified under the Clinical Laboratory Improvement Act of 1988 (CLIA) as qualified to perform high complexity clinical testing and is a College of American Pathology (CAP) Accredited Laboratory.
CLIA ID #05D2168340